Literature DB >> 29779108

MicroRNA-Dependent Regulation of IGF1R Gene Expression in Hormone-Sensitive and Hormone-Resistant Prostate Cancer Cells.

V A Tarasov1, M G Tyutyakina2, M A Makhotkin1, E F Shin1, A V Naboka1, A N Mashkarina1, D A Chebotarev1, E N Cherkasova1, M I Kogan1,3, M B Chibichyan1,3, D G Matishov1.   

Abstract

Using multiple parallel sequencing on Illumina platform, we identified eight microRNAs that showed significant opposite changes of gene expression in cells of the hormone-sensitive LNCaP prostate cancer cell line and in cells of the hormone-resistant DU-145 cell line, in comparison to the microRNA expression in the normal prostate tissue cells. We found that the insulin-like growth factor 1 receptor (IGF1R) gene is a target of five microRNAs whose expression is increased in LNCaP cells and reduced in DU-145 cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29779108     DOI: 10.1134/S1607672918020138

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  13 in total

Review 1.  Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Authors:  Jennifer D Wu; Kathy Haugk; Libby Woodke; Peter Nelson; Ilsa Coleman; Stephen R Plymate
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

2.  Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.

Authors:  Alexandros Tzatsos; Polina Paskaleva; Stephania Lymperi; Gianmarco Contino; Svetlana Stoykova; Zhao Chen; Kwok-Kin Wong; Nabeel Bardeesy
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

Authors:  Qing Xu; Yue Jiang; Yu Yin; Qi Li; Jun He; Yi Jing; Yan-Ting Qi; Qian Xu; Wei Li; Bo Lu; Stephen S Peiper; Bing-Hua Jiang; Ling-Zhi Liu
Journal:  J Mol Cell Biol       Date:  2012-08-29       Impact factor: 6.216

4.  Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R.

Authors:  Honghai Xu; Cong Liu; Yuelin Zhang; Xiong Guo; Zongzhi Liu; Zhenqun Luo; Yanhai Chang; Shizhang Liu; Zhengming Sun; Xiaoqing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-09-30       Impact factor: 3.848

5.  miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression.

Authors:  T Murata; K Takayama; S Katayama; T Urano; K Horie-Inoue; K Ikeda; S Takahashi; C Kawazu; A Hasegawa; Y Ouchi; Y Homma; Y Hayashizaki; S Inoue
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-09-07       Impact factor: 5.554

6.  DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.

Authors:  Fatouma Alimirah; Jianming Chen; Zane Basrawala; Hong Xin; Divaker Choubey
Journal:  FEBS Lett       Date:  2006-03-24       Impact factor: 4.124

7.  miR-148 targets human DNMT3b protein coding region.

Authors:  Anja M Duursma; Martijn Kedde; Mariette Schrier; Carlos le Sage; Reuven Agami
Journal:  RNA       Date:  2008-03-26       Impact factor: 4.942

8.  MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.

Authors:  Jiang Yan; Xiaoqiang Guo; Jiazeng Xia; Tin Shan; Chen Gu; Zheng Liang; Wei Zhao; Shimao Jin
Journal:  Med Oncol       Date:  2014-02-11       Impact factor: 3.064

9.  Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.

Authors:  D Sun; R Layer; A C Mueller; M A Cichewicz; M Negishi; B M Paschal; A Dutta
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

10.  Mechanisms of Androgen-Independent Prostate Cancer.

Authors:  Punit Saraon; Andrei P Drabovich; Keith A Jarvi; Eleftherios P Diamandis
Journal:  EJIFCC       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.